Bioregenx annual total assets
2021
2022
2023
2024
2025
Bioregenx Total Assets Growth & History (BRGX)
Bioregenx's total assets was $410,986 for fiscal 2025.
View full Bioregenx company overviewBioregenx annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $410,986 | −$97,549 | −19.18% |
| 2024 | 2024-12-31 | $508,535 | −$357,215 | −41.26% |
| 2023 | 2023-12-31 | $865,750 | $806,601 | +1363.68% |
| 2022 | 2022-12-31 | $59,149 | −$68,613 | −53.70% |
| 2021 | 2021-12-31 | $127,762 | — | — |
Bioregenx quarterly total assets
Q4.21
Q1.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | $337,070 | −$145,553 | −30.16% |
| Q4 2025 | 2025-12-31 | $410,986 | −$97,549 | −19.18% |
| Q3 2025 | 2025-09-30 | $1.2M | −$16.2M | −93.27% |
| Q2 2025 | 2025-06-30 | $1.2M | −$16.7M | −93.57% |
| Q1 2025 | 2025-03-31 | $482,623 | −$18.1M | −97.41% |
| Q4 2024 | 2024-12-31 | $508,535 | −$357,215 | −41.26% |
| Q3 2024 | 2024-09-30 | $17.4M | — | — |
| Q2 2024 | 2024-06-30 | $17.9M | — | — |
| Q1 2024 | 2024-03-31 | $18.6M | $18.5M | +23775.14% |
| Q4 2023 | 2023-12-31 | $865,750 | — | — |
| Q1 2023 | 2023-03-31 | $77,989 | — | — |
| Q4 2021 | 2021-12-31 | $127,762 | — | — |
Bioregenx total assets trends
Between the periods ended 2021-12-31 and 2025-12-31, Bioregenx's total assets increased from $127,762 to $410,986, a change of $283,224. The latest reported quarter, Q1 2026, shows $337,070.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bioregenx source filings ↗